Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stellate Ganglion Block as Novel Treatment for Heart Failure Patients

NCT06244056 is registered in ClinicalTrials.gov with Mina sobhi said fam as lead sponsor.

NCT NCT06244056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06244056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stellate Ganglion Block as Novel Treatment for Heart Failure Patients
Lead sponsor
Mina sobhi said fam
Phase
Phase 2/3
Overall status
Unknown status
Start date
February 5, 2024
Completion date
January 1, 2025
Enrollment
108 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

stellate ganglion block